ABSTRACT
Objective There is a need in clinical genomics for systems that assist in clinical diagnosis, analysis of genomic information and periodic re-analysis of results, and can utilize information from in the electronic health record to do so. Such systems should be designed using the concepts of human-centered design, fit within clinical workflows, and provide solutions to priority problems.
Materials and methods We adapted a commercially available diagnostic decision support system (DDSS) to use extracted findings from a patient record and combine them with genomic variant information in the DDSS interface. Three simulated patient cases were created, and a structured interview guide was used to assess technical issues, workflow fit, and acceptability. Three testers conducting evaluation of genetic conditions were selected for user testing; 3 additional testers were included to evaluate fit and system implementation potential. Qualitative analysis of test session transcripts was done.
Results Tester responses were positive and noted good fit within real-world clinical genetics workflow. Technical issues related to interface, interaction, and design were minor and fixable. Testers suggested solving issues related to terminology and usability through training and added infobuttons. Time savings was estimated at 30–50% and other uses for in-house clinical variant analysis were noted to increase fit with workflow and address priority problems.
Discussion and Conclusion We provide preliminary evidence that a system including DDSS and automated chart review may help improve efficiency and consistency of genetic diagnosis and addresses perceived needs for clinical end-users. Further development could improve functionality and implementation potential.
Competing Interest Statement
LKF and MMS are employed by SimulConsult and have an ownership stake. All other authors declare no competing interests other than grant funding.
Funding Statement
This study was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number 1R43HG010322-01 (principal investigator: MMS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Geisinger IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
study data are qualitative interview transcripts and are not made publicly available, however, authors may be contacted for information.